David Wu
- Hematology top 2%
- Acute Myeloid Leukemia Research 16
- Chronic Myeloid Leukemia Treatments 9
- Oncology top 2%
-
- Lymphoma Diagnosis and Treatment 24
- Immunology top 5%
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 9
- Genomic variations and chromosomal abnormalities 7
- Genomics and Rare Diseases 6
-
- Cancer Genomics and Diagnostics 17
-
- Acute Lymphoblastic Leukemia research 15
- Co-authors
- Brent L. WoodJonathan R. FrommHarlan RobinsMin FangAnna SherwoodDavid G. MaloneySindhu CherianOlivia Finney
- Journals
- Blood (10 papers)Cytometry Part B Clinical Cytometry (7 papers)American Journal of Clinical Pathology (7 papers)
- Partner nations
- United StatesSouth AfricaGermany
In The Last Decade
David Wu
64 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Hematology 547
- Oncology 1.1k
- Pathology and Forensic Medicine 556
- Immunology 631
- Genetics 289
Countries citing papers authored by David Wu
This map shows the geographic impact of David Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Wu more than expected).
Fields of papers citing papers by David Wu
This network shows the impact of papers produced by David Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Wu. The network helps show where David Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 12 | |
| 6 | 2022 | 7 | |
| 7 | 2021 | 13 | |
| 8 | 2021 | 25 | |
| 9 | 2021 | 2 | |
| 10 | 2019 | 41 | |
| 11 | 2018 | 111 | |
| 12 | 2017 | 130 | |
| 13 | 2017 | 21 | |
| 14 | 2016 | 32 | |
| 15 | 2016 | 10 | |
| 16 | 2016 | 8 | |
| 17 | 2015 | 27 | |
| 18 | 2014 | 106 | |
| 19 | 2012 | 17 | |
| 20 | 1997 | 7 |
About David Wu
David Wu is a scholar working on Hematology, Pathology and Forensic Medicine and Cancer Research, having authored 65 papers that have together received 2.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (24 papers), Cancer Genomics and Diagnostics (17 papers), Acute Myeloid Leukemia Research (16 papers), Acute Lymphoblastic Leukemia research (15 papers), Chronic Lymphocytic Leukemia Research (9 papers), Chronic Myeloid Leukemia Treatments (9 papers), Genomic variations and chromosomal abnormalities (7 papers) and Genomics and Rare Diseases (6 papers). The work is most often cited by research in Hematology (547 citations), Oncology (1.1k citations) and Pathology and Forensic Medicine (556 citations). David Wu has collaborated with scholars based in United States, South Africa and Germany. Frequent co-authors include Brent L. Wood, Jonathan R. Fromm, Harlan Robins, Min Fang, Anna Sherwood, David G. Maloney, Sindhu Cherian, Olivia Finney, Stanley R. Riddell and Cameron J. Turtle. Their work appears in journals such as Blood, Cytometry Part B Clinical Cytometry, American Journal of Clinical Pathology, Biology of Blood and Marrow Transplantation and Journal of Molecular Diagnostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.